Clinical Trials Directory

Trials / Completed

CompletedNCT04126577

Clinical Relevance of the Reverse Lipopolysaccharide Transport Pathway in Patients With Acute Peritonitis

Clinical Relevance of the Reverse Lipopolysaccharide Transport Pathway in Patients With Acute Peritonitis An Observational Prospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
27 (actual)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

When there is infection in the intra-abdominal area, bacteria secrete toxins that are absorbed by the peritoneum. These toxins then bind to lipoproteins (which carry cholesterol in the blood) and are eliminated by the liver. Phospholipid transfer protein (PLTP) is a protein that facilitates the binding of bacterial toxins to lipoproteins and thus their elimination. The objective of this study is to study the relationship between PLTP and the elimination of bacterial toxins in humans. A better understanding of the elimination of these toxins will lead to a better understanding of the disease. The ultimate objective is to improve the management of intra-abdominal infections.

Conditions

Interventions

TypeNameDescription
BIOLOGICALblood samples4 blood samples of 6 ml each: one before the surgical incision, one after the operation, one 4h after the operation and the last 24h after the operation.

Timeline

Start date
2019-12-19
Primary completion
2022-10-27
Completion
2022-10-27
First posted
2019-10-15
Last updated
2023-08-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04126577. Inclusion in this directory is not an endorsement.